TAK

Takeda Pharmaceutical Company Limited

12.68 USD
-0.49 (-3.72%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Takeda Pharmaceutical Company Limited stock is down -4.52% since 30 days ago. The next earnings date is Jul 25, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 35.29% of the previous 16 June’s closed higher than May.

About Takeda Pharmaceutical Company Limited

Takeda Pharmaceutical Company Limited engages in the research, development, manufacturing, marketing, and out-licensing of pharmaceutical products. It offers pharmaceutical products in gastroenterology; oncology; neuroscience; and rare diseases. The company provides its products under the Entyvio, Gattex/Revestive, Alofisel, Natpara, Adynovate/Adynovi, Takhzyro, Elaprase, Vpriv, Gammagard Liquid/Kiovig.